2. As of noon trading, Merck ( MRK) is down $0.32 (-0.6%) to $49.47 on light volume. Thus far, 3.6 million shares of Merck exchanged hands as compared to its average daily volume of 12.3 million shares. The stock has ranged in price between $49.34-$50.00 after having opened the day at $49.82 as compared to the previous trading day's close of $49.79.

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. Merck has a market cap of $146.4 billion and is part of the health care sector. The company has a P/E ratio of 33.6, above the S&P 500 P/E ratio of 17.7. Shares are down 0.5% year to date as of the close of trading on Wednesday. Currently there are 5 analysts that rate Merck a buy, 1 analyst rates it a sell, and 8 rate it a hold.

TheStreet Ratings rates Merck as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Merck Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Regeneron Pharmaceuticals Ready to Make All-Time Highs

Regeneron, BioMarin, AbbVie Could Explode 20% or More -- Analyst

Biotech movers: CEL-SCI Leaps After FDA Lets Cancer Study Move Forward

If It's Not Earnings News, It's Amazon Competition: Jim Cramer's Best Blog

Electronic Arts, Activision Blizzard and Take-Two Interactive: 'Mad Money' Lightning Round